Immune activation underlies a sustained clinical response to Yttrium-90 radioembolisation in hepatocellular carcinoma

OBJECTIVES: Yttrium-90 (Y90)-radioembolisation (RE) significantly regresses locally advanced hepatocellular carcinoma and delays disease progression. The current study is designed to deeply interrogate the immunological impact of Y90-RE, which elicits a sustained therapeutic response. DESIGN: Time-o...

Descripción completa

Detalles Bibliográficos
Autores principales: Chew, Valerie, Lee, Yun Hua, Pan, Lu, Nasir, Nurul J M, Lim, Chun Jye, Chua, Camillus, Lai, Liyun, Hazirah, Sharifah Nur, Lim, Tony Kiat Hon, Goh, Brian K P, Chung, Alexander, Lo, Richard H G, Ng, David, Filarca, Rene L F, Albani, Salvatore, Chow, Pierce K H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Hepatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352403/
https://www.ncbi.nlm.nih.gov/pubmed/29440463
http://dx.doi.org/10.1136/gutjnl-2017-315485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352403/
https://www.ncbi.nlm.nih.gov/pubmed/29440463
http://dx.doi.org/10.1136/gutjnl-2017-315485

Ejemplares similares